The session will review the latest clinical information regarding cannabis use for medical purposes. Particular attention will be given to the latest information regarding treating inflammatory bowel diseases and neurologic disorders. Pulmonary and cardiovascular risks will be reviewed. The speaker will also discuss marijuana use for the elderly and inform participants about issues related to impaired driving.

Over 40% of men over the age of 50 will suffer from erectile dysfunction (ED) or hypogonadism and these conditions often co-exist in many men. Clinicians should be aware of the new 2018 American Urologic Association (AUA) ED guidelines and how the paradigm of ED treatments has now changed. In addition, over the past 5 years there have been numerous controversies with the diagnosis and management of hypogonadism. Clinicians should be aware of these controversies and should be familiar with the new 2018 AUA and Endocrine guideline on testosterone therapy.

This talk will be aimed for primary care physicians with a goal of understanding and defining CKD as its prevalence continues to rise in the era of hypertension, diabetes and obesity epidemics. The attendant will understand and identify patients at risk and with CKD and the natural course of the disease. They will be supplied with tools clinically proven to slow down progression of the disease and understand the denouement of CKD.

In this activity, Dr. Eslami will give an overview of an ambulatory approach to the evaluation and medical management of urinary incontinence by identifying the steps involved for performing a basic evaluation of a patient with urinary incontinence. She will discuss and provide strategies for treatment and explain how treatment can be optimized for each individual patient.

This talk will update participant knowledge about hormone therapy for menopause, focusing on our current understanding of the myths, benefits, and harms of treatment. The myth that hormone therapy is, in general, harmful, is based on data looking at the consequences of hormone therapy in individuals aged 60 and older. In contrast, the data on most individuals who are either under age 60 or less than 10 years from menopause show that the benefits appear to outweigh the risks. A clinical practice guideline published by the Endocrine Society recommends an individualized approach to treatment based on calculating baseline cardiovascular and breast cancer before initiating therapy. The benefits of hormone therapy for menopause include management of hot flashes and vaginal atrophy. It is not recommended for the prevention of cardiovascular disease, osteoporosis, or dementia. In the Women’s Health Initiative combined hormone therapy trial, risks included coronary events, stroke, venous thromboembolism, and breast cancer. No increase in either coronary heart disease or breast cancer risk was seen with unopposed estrogen. These results suggest that the progestin played an important role in the increased coronary and breast cancer risk seen with combined therapy.

This talk will review current breast cancer screening guidelines. It will explain different modalities used to screen for breast cancer. Dr. Marcus will discuss factors to consider in initiating screening and when to stop routine screening for breast cancer. She will also talk about how to explain inconclusive findings and breast density to patients.

Using Choosing Wisely, AAP, and CDC recommendations as a foundation, the faculty will review the evidence-based guidelines for the following topics: diagnosis/management of upper respiratory infections (e.g., otitis media), the efficacy of PPI/H2B in young children, the new updates in blood pressure screening, universal HIV screening in adolescents, and mental health tools that assist in screening for depression, anxiety, and ADHD.

The session will overview the challenge and impact of burnout, explore factors that threaten individual and organizational wellness, and discuss evidence-based strategies for leading change at the personal and the systems level. Participants will have an opportunity to reflect on personal health priorities while strengthening their commitment to a culture of wellness. They will discuss the process of change and critically analyze and choose areas for personal improvement beginning with a needs assessment and ending with an actionable health improvement plan. Participants will receive time, tools and strategies to succeed personally and to partner with colleagues to create greater impact.

This lecture will address the diagnosis and treatment of common sexually transmitted diseases.

Guidelines for immunizations and cancer screening recommendations are constantly in flux as new data emerges. This session will review some current recommendations for vaccinations and cancer screening in children and adults in addition to controversies related to these recommendations.

The speaker will describe the most common foot pathology and offer appropriate treatments. Learners will observe the differential diagnosis for many of the foot problems and walk away with clinical pearls.

Using a case-based approach, the speaker will discuss the current state of menopausal hormone therapy and management strategies for patients who are not candidates for hormonal options. This talk will provide audience members with a review of recent publications that impact the management of patients’ menopausal symptoms.